Taiko Pharmaceutical Co. Ltd. | Mutual Funds
Mutual Funds that own Taiko Pharmaceutical Co. Ltd.
Nomura Asset TOPIX ETF Fund (1306)
167,500
1.18%
2,600
0%
07/31/2018
Daiwa Asset TOPIX Listed ETF (1305)
82,200
0.57%
-200
0%
07/31/2018
Nikko Asset Listed Index TOPIX ETF (1308)
75,600
0.53%
0
0%
08/20/2018
Fidelity Japan Japanese Growth Equity Mother Fund
61,399
0.43%
61,399
0.02%
11/30/2017
SEI Institutional Managed Trust - Global Managed Vol. Fund
23,500
0.17%
-4,900
0.03%
08/31/2018
Mitsubishi UFJ MAXIS TOPIX ETF (1348)
22,000
0.15%
600
0%
07/31/2018
DFA Japanese Small Company Series
20,600
0.14%
-46,200
0.01%
01/31/2018
SPDR S&P International Small Cap ETF
13,300
0.09%
0
0.03%
09/06/2018
DFA International Core Equity Portfolio
12,600
0.09%
-900
0%
04/30/2018
SEI Global Master Fund Plc - Global Managed Volatility
8,100
0.06%
0
0.01%
05/31/2018
| Address |
ORIX Honmachi Building, 16F
Osaka Osaka 550
Japan
|
|
Employees
|
- |
| Website |
http://www.seirogan.co.jp |
| Updated |
07/08/2019 |
| Taiko Pharmaceutical Co., Ltd. engages in the manufacture and sale of general medications particularly non-prescription gastrointestinal drugs and designated quasi drugs, and sanitation control products. It operates through the following segments: Pharmaceuticals, Infection Control, and Others. The Pharmaceuticals segment handles the manufacture, procurement and sale of non-prescription (OTC) drugs in Japan and overseas. |
